(8S,9S,10R,11S,13S,14S,17R)-17-((S)-1,2-Dihydroxyethyl)-11,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one, Prednisolone Impurity, 98%

cas: 2299-46-9 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

(8S,9S,10R,11S,13S,14S,17R)-17-((S)-1,2-Dihydroxyethyl)-11,17-dihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one, Prednisolone Impurity, 98% (CAS 2299-46-9) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 100mg. Oferty producentów: Fluorochem.

• 2D
• 3D

(8S,9S,10R,11S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (CAS 2299-46-9) to związek chemiczny o wzorze sumarycznym C21H30O5 i masie molowej 362.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one. InChIKey: LCOVYWIXMAJCDS-FJWDNACWSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C21H30O5
Masa molowa	362.5 g/mol
Nazwa IUPAC	(8S,9S,10R,11S,13S,14S,17R)-17-[(1S)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
InChIKey	LCOVYWIXMAJCDS-FJWDNACWSA-N
SMILES	C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2([C@H](CO)O)O)CCC4=CC(=O)C=C[C@]34C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (11beta,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one, 20(S)-Hydroxy Prednisolone, Prednisolone EP Impurity G, 20a-Hydroxy Prednisolone, 20alpha-dihydroprednisolone, 20beta-hydroxyprednisolone, 20beta-Dihydroprednisolone, Prednisolone impurity G [EP], Pregna-1,4-dien-3-one, 11,17,20,21-tetrahydroxy-, (11beta,20S)-, (20S)-Hydroxyprednisolone

Powiązane formy tego związku

(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

Izomery (ten sam wzór sumaryczny)

6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C₂₁H₃₀O₅

(8S,10R,11S,13S)-9,11,12,12-tetradeuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

2-[[(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid C₂₁H₃₀O₅

2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]acetic acid C₂₁H₃₀O₅

(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one C₂₁H₃₀O₅

(8S,9S,10R,11S,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅

(8S,9S,10R,11S,13S,14S,17S)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C₂₁H₃₀O₅